Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Vanda Pharmaceuticals (VNDA) Other Gross PP&E Adjustments (2016 - 2025)

Vanda Pharmaceuticals' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at $7.5 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 14.1% year-over-year to $7.5 million; the TTM value through Dec 2025 reached $7.5 million, down 14.1%, while the annual FY2025 figure was $7.5 million, 14.1% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $7.5 million at Vanda Pharmaceuticals, up from -$6.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $8.8 million in Q4 2024 and bottomed at -$12.0 million in Q1 2024.
  • The 5-year median for Other Gross PP&E Adjustments is -$8.6 million (2022), against an average of -$5.5 million.
  • The largest annual shift saw Other Gross PP&E Adjustments surged 88.74% in 2021 before it decreased 29.92% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $3.2 million in 2021, then soared by 42.7% to $4.6 million in 2022, then surged by 33.17% to $6.1 million in 2023, then surged by 43.19% to $8.8 million in 2024, then dropped by 14.1% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Other Gross PP&E Adjustments are $7.5 million (Q4 2025), -$6.8 million (Q3 2025), and -$8.3 million (Q2 2025).